Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005

Pediatrics

Volumn 123, Issue 2, 2009, Pages 524-532

  Burke, Bryan L ^a   Robbins, James M ^a   Bird, T Mac ^a   Hobbs, Charlotte A ^a   Nesmith, Clare ^a   Tilford, John Mick ^a,b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b Center for Applied Research and Evaluation   (United States)

Author keywords

Hyperbilirubinemia; Jaundice; Kernicterus; Neonatal

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXCHANGE BLOOD TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; INFANT; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN JAUNDICE; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; JAUNDICE; NEWBORN;

FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; JAUNDICE; KERNICTERUS; MALE; UNITED STATES;

EID: 61549133569     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2915     Document Type: Article

References (46)

1. Halamek LP, Stevenson DK. Neonatal jaundice and liver disease. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine: Diseases of the Fetus and Neonate. 7th ed. St Louis, MO: Mosby; 2002:1324
2. Bhutani VK, Johnson LH, Shapiro SM. Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach. Semin Perinatal. 2004;28(5):319-325
3. American Academy of Pediatrics, Subcommittee on Hyperbiliru- binemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004;114(1):297-316
4. Ip S, Chung M, Kulig J, O'Brien R, et al. An evidence-based review of important issues concerning neonatal hyperbiliru- binemia. Pediatrics. 2004;114(1). Available at: www.pediatrics. org/cgi/content/full/114/1/e130
5. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of ker- nicterus. J Pediatr. 2002;140(4):396-403
6. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbiliru- binemia. Practice parameter: management of hyperbiliru- binemia in the healthy term newborn. Pediatrics. 1994;94(4 pt1):558 -565
7. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89(10)1213-1127:
8. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587-590
9. Joint Commission on Accreditation of Healthcare Organizations. Kernicterus threatens healthy newborns. Sentinal Event Alert. 2001;18:1-4
10. Seidman DS, Paz I, Armon Y, Ergaz Z, Stevenson DK, Gale R. Effect of publication of the "Practice Parameter for the management of hyperbilirubinemia" on treatment of neonatal jaundice. Acta Paediatr. 2001;90(3):292-295
11. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89(5 pt 1):809-818
12. Brown AK, Seidman DS, Stevenson DK. Jaundice in healthy, term neonates: do we need new action levels or new approaches? Pediatrics. 1992;89(5 pt 1):827-829
13. Newman TB, Maisels MJ. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics. 2000;105(1 pt 3):242-245
14. Suresh GK, Clark RE. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics. 2004;114(4):917-924
15. Bhutani V, Johnson LH. Kernicterus: lessons for the future from a current tragedy. NeoReviews. 2003;4(2):e30-e32
16. Bhutani VK, Johnson LH, Jeffrey MM, et al. Kernicterus: epi- demiological strategies for its prevention through systems- based approaches. J Perinatol. 2004;24(10):650 -662
17. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993;92(5):651-657
18. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154(11):1140-1147
19. Maisels MJ, Newman TB. Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border. CMAJ. 2006;175(6):599
20. Kernicterus in full-term infants: United States, 1994-1998. MMWR Morb Mortal Wkly Rep. 2001;50(23):491-494
21. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118(3):1207-1214
22. Blackmon LR, Fanaroff AA, Raju TN. Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary, 2003. Pediatrics. 2004;114(1):229-233
23. Healthcare Cost and Utilization Project (HCUP). The HCUP Nationwide Inpatient Sample (NIS). Rockville, MD: Agency for Healthcare Research and Quality; 2004
24. Healthcare Cost and Utilization Project (HCUP). The HCUP Kids' Inpatient Database (KID). Rockville, MD: Agency for Healthcare Research and Quality; 2005
25. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112(3 pt 1):495-501
26. Healthcare Cost and Utilization Project. 2003 Kids' Inpatient Database (KID) Technical Documentation. Rockville, MD: Agency for Healthcare Research and Quality; 2005
27. Healthcare Cost and Utilization Project. 2002 Nationwide Inpa- tient Sample Technical Documentation. Rockville, MD: Agency for Healthcare Research and Quality; 2004
28. Bird TM, Hobbs CA, Cleves MA, Tilford JM, Robbins JM. National rates of birth defects among hospitalized newborns. Birth Defects Res A Clin Mol Teratol. 2006;76(11):762-769
29. Robbins JM, Tilford JM, Bird TM, Cleves MA, Reading JA, Hobbs CA. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid. Pediatrics. 2006;118(3):906-915
30. Robbins JM, Bird TM, Tilford JM, et al. Reduction in newborns with discharge coding of in utero alcohol effects in the United States, 1993 to 2002. Arch Pediatr Adolesc Med. 2006;160(12):1224 -1231
31. Westfall JM, McGloin J. Impact of double counting and transfer bias on estimated rates and outcomes of acute myocardial infarction. Med Care. 2001;39(5):459-468
32. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ash- ton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5 pt 2):1620-1639
33. Berthelsen CL. Evaluation of coding data quality of the HCUP National Inpatient Sample. Top Health Inf Manage. 2000;21(2): 10-23
34. Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994;93(6 pt 1):1003-1006
35. MacDonald MG. Hidden risks: early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency. Pediatrics. 1995;96(4pt 1):734-738
36. Brown AK, Johnson L. Loss of concern about jaundice an the reemergence of kernicterus in full term infants in the era of managed care. In: Fanaroff AA, Klaus M, eds. The Yearbook of Neonatal and Perinatal Medicine. St Louis, MO: Mosby; 1996:17-28
37. Clancy CM. Getting to "smart" health care. Health Aff (Millwood). 2006;25(6):w589-w592
38. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;120(1):27-32
39. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997;99(5). Available at: www.pediatrics.org/cgi/content/full/99/5/e7
40. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144(5):626-631
41. Lucey JF. The future demise of exchange transfusions for neonatal hyperbilirubinemia. Dev Med Child Neurol. 1968;10(4):521-522
42. Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104(5 pt 2):1198-1203
43. Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889-1900
44. Ebbesen F, Andersson C, Verder H, et al. Extreme hyperbiliru- binaemia in term and near-term infants in Denmark. Acta Paediatr. 2005;94(1):59 -64
45. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111(6 pt 1):1303-1311
46. Manning D, Todd P, Maxwell M, Jane PM. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007; 92(5):F342-F346